Using time-dependent covariates in the Cox model THIS MATERIAL IS NOT REQUIRED FOR YOUR METHODS II EXAM With some examples taken from Fisher and Lin (1999)

Slides:



Advertisements
Similar presentations
Agency for Healthcare Research and Quality (AHRQ)
Advertisements

Surviving Survival Analysis
Survival Analysis. Key variable = time until some event time from treatment to death time for a fracture to heal time from surgery to relapse.
How would you explain the smoking paradox. Smokers fair better after an infarction in hospital than non-smokers. This apparently disagrees with the view.
If we use a logistic model, we do not have the problem of suggesting risks greater than 1 or less than 0 for some values of X: E[1{outcome = 1} ] = exp(a+bX)/
Study Designs in Epidemiologic
Survival Analysis. Statistical methods for analyzing longitudinal data on the occurrence of events. Events may include death, injury, onset of illness,
PHSSR IG CyberSeminar Introductory Remarks Bryan Dowd Division of Health Policy and Management School of Public Health University of Minnesota.
Observational Studies Based on Rosenbaum (2002) David Madigan Rosenbaum, P.R. (2002). Observational Studies (2 nd edition). Springer.
Statistical Issues in Contraceptive Trials
Categorical Data. To identify any association between two categorical data. Example: 1,073 subjects of both genders were recruited for a study where the.
The role of economic modelling – a brief introduction Francis Ruiz NICE International © NICE 2014.
April 25 Exam April 27 (bring calculator with exp) Cox-Regression
بسم الله الرحمن الرحیم. Generally,survival analysis is a collection of statistical procedures for data analysis for which the outcome variable of.
Analysis of Time to Event Data
Intermediate methods in observational epidemiology 2008 Instructor: Moyses Szklo Measures of Disease Frequency.
Event History Analysis: Introduction Sociology 229 Class 3 Copyright © 2010 by Evan Schofer Do not copy or distribute without permission.
Introduction to Survival Analysis
BIOST 536 Lecture 3 1 Lecture 3 – Overview of study designs Prospective/retrospective  Prospective cohort study: Subjects followed; data collection in.
Chapter 11 Survival Analysis Part 2. 2 Survival Analysis and Regression Combine lots of information Combine lots of information Look at several variables.
Introduction to Survival Analysis PROC LIFETEST and Survival Curves.
Main Points to be Covered Cumulative incidence using life table method Difference between cumulative incidence based on proportion of persons at risk and.
Measures of disease frequency (I). MEASURES OF DISEASE FREQUENCY Absolute measures of disease frequency: –Incidence –Prevalence –Odds Measures of association:
Cohort Studies Hanna E. Bloomfield, MD, MPH Professor of Medicine Associate Chief of Staff, Research Minneapolis VA Medical Center.
Cox Proportional Hazards Regression Model Mai Zhou Department of Statistics University of Kentucky.
Analysis of Complex Survey Data
Body Mass Index, Weight Change and Death in an Older Hypertensive Population: The SHEP Study Grant W Somes Stephen B Kritchevsky Marco Pahor Ronald I Shorr.
Marshall University School of Medicine Department of Biochemistry and Microbiology BMS 617 Lecture 12: Multiple and Logistic Regression Marshall University.
Survival Analysis: From Square One to Square Two
Introduction to Survival Analysis August 3 and 5, 2004.
Estimating cancer survival and clinical outcome based on genetic tumor progression scores Jörg Rahnenführer 1,*, Niko Beerenwinkel 1,, Wolfgang A. Schulz.
Inference for proportions - Comparing 2 proportions IPS chapter 8.2 © 2006 W.H. Freeman and Company.
Essentials of survival analysis How to practice evidence based oncology European School of Oncology July 2004 Antwerp, Belgium Dr. Iztok Hozo Professor.
“While nothing is more uncertain than a single life, nothing is more certain than the average duration of a thousand lives” -Elizur Wright By: Gail Larsen.
Assessing Survival: Cox Proportional Hazards Model
D:/rg/folien/ms/ms-USA ppt F 1 Assessment of prediction error of risk prediction models Thomas Gerds and Martin Schumacher Institute of Medical.
Time-dependent covariates and further remarks on likelihood construction Presenter Li,Yin Nov. 24.
“Further Modeling Issues in Event History Analysis by Robert E. Wright University of Strathclyde, CEPR-London, IZA-Bonn and Scotecon.
INTRODUCTION TO SURVIVAL ANALYSIS
Chapter 12 Survival Analysis.
01/20151 EPI 5344: Survival Analysis in Epidemiology Time varying covariates March 24, 2015 Dr. N. Birkett, School of Epidemiology, Public Health & Preventive.
01/20151 EPI 5344: Survival Analysis in Epidemiology Survival curve comparison (non-regression methods) March 3, 2015 Dr. N. Birkett, School of Epidemiology,
Introduction to Survival Analysis Utah State University January 28, 2008 Bill Welbourn.
1 1 Using Marginal Structural Model to Estimate and Adjust for Causal Effect of Post- discontinuation Chemotherapy on Survival in Cancer Trials Y. Wang,
HSRP 734: Advanced Statistical Methods July 31, 2008.
CREATE Biostatistics Core THRio Statistical Considerations Analysis Plan.
Lecture 15: Time Varying Covariates Time-varying covariates.
Study Designs for Clinical and Epidemiological Research Carla J. Alvarado, MS, CIC University of Wisconsin-Madison (608)
Lecture 9: Analysis of intervention studies Randomized trial - categorical outcome Measures of risk: –incidence rate of an adverse event (death, etc) It.
Survival Analysis 1 Always be contented, be grateful, be understanding and be compassionate.
Parametric Conditional Frailty Models for Recurrent Cardiovascular Events in the LIPID Study Dr Jisheng Cui Deakin University, Melbourne.
01/20151 EPI 5344: Survival Analysis in Epidemiology Cox regression: Introduction March 17, 2015 Dr. N. Birkett, School of Epidemiology, Public Health.
Satistics 2621 Statistics 262: Intermediate Biostatistics Jonathan Taylor and Kristin Cobb April 20, 2004: Introduction to Survival Analysis.
Copyright © 2013, 2009, and 2007, Pearson Education, Inc. Chapter 10 Comparing Two Groups Section 10.1 Categorical Response: Comparing Two Proportions.
Biostatistics Case Studies 2014 Youngju Pak Biostatistician Session 5: Survival Analysis Fundamentals.
1 Using dynamic path analysis to estimate direct and indirect effects of treatment and other fixed covariates in the presence of an internal time-dependent.
01/20151 EPI 5344: Survival Analysis in Epidemiology Estimating S(t) from Cox models March 24, 2015 Dr. N. Birkett, School of Epidemiology, Public Health.
01/20151 EPI 5344: Survival Analysis in Epidemiology Hazard March 3, 2015 Dr. N. Birkett, School of Epidemiology, Public Health & Preventive Medicine,
INTRODUCTION TO CLINICAL RESEARCH Survival Analysis – Getting Started Karen Bandeen-Roche, Ph.D. July 20, 2010.
1 Pulminiq™ Cyclosporine Inhalation Solution Pulmonary Drug Advisory Committee Meeting June 6, 2005 Statistical Evaluation Statistical Evaluation Jyoti.
Case-Control Studies September 2014 Alexander M. Walker MD, DrPH With Sonia Hernández-Díaz MD, DrPH.
02/20161 EPI 5344: Survival Analysis in Epidemiology Hazard March 8, 2016 Dr. N. Birkett, School of Epidemiology, Public Health & Preventive Medicine,
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Smoking Is Associated With Adverse Clinical Outcomes.
Marshall University School of Medicine Department of Biochemistry and Microbiology BMS 617 Lecture 13: Multiple, Logistic and Proportional Hazards Regression.
SURVIVAL ANALYSIS PRESENTED BY: DR SANJAYA KUMAR SAHOO PGT,AIIH&PH,KOLKATA.
03/20161 EPI 5344: Survival Analysis in Epidemiology Estimating S(t) from Cox models March 29, 2016 Dr. N. Birkett, School of Epidemiology, Public Health.
Methods and Statistical analysis. A brief presentation. Markos Kashiouris, M.D.
Carolinas Medical Center, Charlotte, NC Website:
Anja Schiel, PhD Statistician / Norwegian Medicines Agency
Presentation transcript:

Using time-dependent covariates in the Cox model THIS MATERIAL IS NOT REQUIRED FOR YOUR METHODS II EXAM With some examples taken from Fisher and Lin (1999) American Review of Public Health.

Examples of time-dependent covariates 1)Discrete events (recurrent MIs) 2)Exposure Histories (smoking history) 3)History of vital measures (heart-rate every 4 months)

Time  Covariate Value t How to model the effect of covariate history on the hazard? h(t)

-Instantaneous effect -Lagged effect -Cumulative effect - Attenuation after a spike in exposure How to model the effect of covariate history on the hazard?

Time  Current Smoker death yes no Example: Using current smoking status to model the hazard of death

Example: Cholesterol-lowering drugs Covariate Value High blood lipid levels  lipid build-up in vascular lesions Low blood lipid levels  leaching from established build-up Lipid build-up  hazard of death

“Simplest” case involves a single instantaneous change in an otherwise constant value.

Time  Treatment Initiated Models for treatment effects: Constant effect of treatment 0 1 V(t)

Time  Treatment Initiated Models for treatment effects: Time  Treatment Initiated Temporary Benefit Increasing Effect 0 0

Time  Long-term Risks associated with interventions: Time  Year 1 Time  Intervention period

Time-dependent covariates lead to complex modeling decisions: - Many more modeling options compared to fixed covariates - Models can be very interesting, or very misleading - The choice of a model and the interpretation of its fit to data can depend heavily on background knowledge. - Danger of overfitting is increased

Time-dependent covariates create more opportunities for confounding: Are marker and event both associated with some underlying temporal process? Example: Circadian Rhythms: Time  Underlying Circadian Rhythm Drug plasma level Hazard of Death

Time-dependent covariates create more opportunities for confounding: Treatment assignment and health status: Consider a bad health outcome that increases the hazard of death and also triggers a particular treatment assignment. Age: Things that accumulate over time are associated with age, and therefore with the hazard of death. Important to appropriately control for age.

With time-dependent covariates, standard methods may not be Appropriate for predicting survival With fixed covariates, we can estimate Pr( survive beyond time t given baseline measures) The corresponding quantity for a model with time dependent covariates is Pr( survive beyond time t given covariate history ) The properties of this quantity depend on the kinds of covariates In our model.

“External” covariates - External to the failure process. - Future covariate values don’t depend on whether or not the patient dies today. -Equivalently, a patient’s prob. of instant death depends only the covariate history up to the present, not on future covariate values. - Examples: Air Pollution, pre-defined treatment regimes, fixed covariates. If all of our covariates are external then we can estimate Pr( survive beyond time t given covariate history ) as long as we plug in a covariate history (but where do we get that?).

“External” covariates - External to the failure process. - Future covariate values don’t depend on whether or not the patient dies today. -Equivalently, a patient’s prob. of instant death depends only the covariate history up to the present, not on future covariate values. - Examples: Air Pollution, pre-defined treatment regimes, fixed covariates. If all of our covariates are external then we can estimate Pr( survive beyond time t given covariate history ) as long as we plug in a covariate history (but where do we get that?).

-For external covariates: A patient’s prob. of instant death depends only the covariate history up to the present, not on future covariate values. -This is a special property—not true for all covariates—even though we model the hazard only as a function of past history. Consider: Asthma exacerbation / air pollution stroke / ICU visit Does knowing the covariate value on Thursday tell you anything more about the probability of event on Wednesday given that you know all covariate values up to and including Wednesday’s?

“Internal” covariates - Internal to the failure process. - Formally, not external - Can require survival of patient for measurement -Examples: blood pressure, or any other vital measure, number of recurrent events, etc. If our model contains internal covariates then we often know Pr( survive beyond time t given covariate history ) with certainty—it is either 0 or 1 depending on whether we have measurements at time t.

Of course one can always condition on covariate history and survival up to a certain point in time, say t0, then stratify patients and compute empirical survival curves for times beyond t0 for each group. This doesn’t use a model for the hazard to predict survival for individual patients. It just gives an aggregate prediction for each group. Suppose our time-varying covariate is time of recurrent MI. Can we just divide the population into two groups, those with and without recurrent MI, and estimate survival curves in each group?

Implementation issues for time-dependent covariates

Follow-up time  Patient Histories Censored survival data

Follow-up time  Patient Histories … with time-dependent covariates

Follow-up time  Patient Histories

Follow-up time  Patient Histories

Follow-up time  Patient Histories Cox model’s view of survival data with time-dependent covariates

Follow-up time  Patient Histories a ba b 1) Split each subject’s history into little intervals between successive failure times 2) Assign each interval the covariate Values at its endpoint. 3) Unless the interval ends in an observed failure, code it as censored. d c

Note that this process will generate a table with approximately (num. patients) x (num unique failure times) / 2 rows. In a large trial with ~14,000 patients and 900 unique failure time This would give > 6 million rows!

Follow-up time  Patient Histories When the covariate only changes value a few times, it may be easier to Split the data only at these change points:

This will lead to roughly (num. patients) + (num change-points) rows in the table. - It’s best to chose the splitting strategy that results in the fewest intervals - Of course if the time-dependent covariate is continuous, we must split by every failure time. - Once the data have been appropriately split, they can be fed into any program that fits Cox models for fixed covariates.

Example

Basline (index MI) Recurrent MI t ME For patients with recurrent MI:

Basline (index MI) Recurrent MI t RE Hypothesis is that durations R and E should influence the hazard of death at time t when there is a recurrent MI. How should we model the effect of R and E ?

Is it better to have an early or later recurrent MI?